Ziprasidone Hydrochloride Capsule
Product Images NDC 68001-451

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ziprasidone Hydrochloride (NDC 68001-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ziprasidone Fig1

This is a description of prescription medicine identified as "Ziprasidone Capsules USP". The medicine formulation contains 20 mg of Ziprasidone hydrochloride USP in each capsule, and it is manufactured by Aurobindo Pharma Limited located in India. The medicine bottles are distributed by BluePoint Laboratories. The recommended dosage and further details about the medicine can be found in the attached prescription information. Correct storage temperature is stated to be between 20°C to 25°C (68°F to 77°F). The document was issued in July 2020.*

FDA Label Image

Ziprasidone Capsules Usp 40 mg (Ziprasidone Fig3)

This is a prescription medication called Ziprasidone, which comes in a 40mg capsule form. Each capsule contains 1040mg of Ziprasidone hydrochloride USP equivalent. The recommended dosage is outlined in the prescribing information that accompanies the medication. The medication should be stored at a controlled room temperature between 20°C and 25°C (68°F and 77°F). It is manufactured by Aurobindo Pharma Limited in India and is distributed by BluePoint Laboratories. The medication was issued in July 2020.*

FDA Label Image

Ziprasidone Capsules Usp 60 mg (Ziprasidone Fig5)

This is a product description for ziprasidone hydrochloride capsules manufactured by Aurobindo Pharma Limited. Each capsule contains 0.60 mg ziprasidone and the product is distributed by BluePoint Laboratories. The capsules are only available with a prescription and the usual dosage should be determined by accompanying prescribing information. The capsules should be stored at a temperature between 20° to 25°C and the package includes 60 capsules.*

FDA Label Image

Ziprasidone Fig7

This is a description of Ziprasidone, a prescription medication used to treat psychiatric conditions. The medication comes in capsule form and the standard dosage is listed in the accompanying prescribing information. The capsules contain 80mg of Ziprasidone, and are manufactured by Aurcbindo Pharma Limited in India. The medication should be stored at controlled room temperature as specified by USP guidelines. The text also includes the drug identification code (NDC 68001-453-06) and the manufacturing date (07/2020).*

FDA Label Image

Chemical Structure (Ziprasidone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.